TELUS-INTERNATIONAL
6.7.2021 12:47:10 CEST | Business Wire | Press release
TELUS International (NYSE and TSX: TIXT), a leading digital customer experience (DCX) innovator that designs, builds and delivers next-generation solutions for global and disruptive brands, today announced the acquisition of Bangalore-based Playment, a leader in data annotation and computer vision tools and services specialized in 2D and 3D image, video and LiDAR (light detection and ranging) - a remote sensing method that uses laser pulses to measure variable distances. The acquisition follows TELUS International’s recent purchase of Lionbridge AI and builds upon the company’s existing deep domain expertise and experience in data annotation, uniquely positioning TELUS International to support technology and large enterprise clients developing AI-powered solutions across a variety of vertical markets.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210706005219/en/
“We are very excited to welcome Playment and its highly engaged, world-class product and engineering team to our TELUS International family today. The acquisition will meaningfully accelerate our company’s computer vision capabilities and further bolster our position at the forefront of our global peers with respect to technology innovation, strategy excellence and talent,” said Jeff Puritt, president and CEO of TELUS International. “As one of the key enabling technologies for today’s advanced AI applications, computer vision is among the most revolutionary technologies of our generation with applications across every sector of the economy. The technology has become increasingly valuable to tech firms and the wider market as brands seek to uncover solutions for scenarios that typically require complex human judgement from visual and spatial patterns to solve nuanced business challenges, and build innovative, market-leading smart products and services.”
The computer vision market is forecast to grow from nearly $16 billion in 2021 to more than $50 billion by 2026, according to an analysis by MarketsandMarkets. The technology is disrupting entire industries and driving transformational societal changes from supporting diagnoses in healthcare, to reducing fraud in banking, to improving e-commerce experiences through enhanced visual search features. In agriculture, for example, advanced farming processes powered by computer vision and AI can provide early and accurate detection and diagnosis of plant diseases based on a green-color ratio and other visual cues to reduce losses in crop yields. In harvesting, computer vision and AI systems can automatically grade and sort food items based on trained parameters, for example, in one fruit detection method, color cameras identify apples on trees that are ready to be picked, and additional stereo cameras detect their relative position for automatic harvesting by a robotic vacuum.
“Standing still is not an option for any company in any industry, but developing and powering the innovations of tomorrow requires a large and continuous supply chain of high-quality image and video training data, which also happens to be the most significant bottleneck in AI development,” shared Puritt. “With the addition of Playment’s expertise, ingenuity and proprietary data annotation platform, TELUS International is more strongly positioned than ever to meet our clients’ current and future needs to support their ongoing growth and evolution. As we continue to expand and evolve as a team and as a company, our focus will remain on empowering our clients to meet the accelerated pace of change in today’s digital world and creating long-term value for our clients, shareholders, team members and the communities where we operate.”
Playment was founded in 2015 and received funding from Elevation Capital (formerly SAIF Partners) and Y Combinator in the early phases of its development. Playment provides fully managed data annotation services that include AI strategy consulting and a SaaS-based platform that transforms videos and images into high-quality annotated data to support a broad range of use cases, ranging from computer vision and data categorization to search relevance. With a focus on data security, user experience and efficiency, and by engaging India’s largest on-demand skilled and secure workforce, Playment has established a hyper-productive environment that delivers datasets faster than its competitors.
“We are thrilled to embark upon the exciting journey ahead with the TELUS International team to harness the full potential of computer vision technology and to advance our joint mission of expediting the AI age through our many partnerships with brands around the world,” said Siddharth Mall, co-founder and CEO of Playment. “We look forward to growing our engagements with existing clients and having the opportunity to work with others that are currently supported by TELUS International to demonstrate the art of the possible through our complementary add-on image, video and LiDAR data annotation capabilities and computer vision expertise. By amplifying our R&D efforts to further extend our product leadership in the industry, and leveraging TELUS International’s global presence to accelerate our go-to-market strategy, together we will help drive disruption across all industry verticals, including in automotive, retail, Internet of Things (IoT), financial services, healthcare, and agriculture.”
TELUS International operates in more than 25 countries around the world with a diverse, multilingual team of more than 50,000 team members, and a global AI Community of more than one million trained data annotators and linguists spread across six continents. To learn more about TELUS International AI Data Solutions, visit www.telusinternational.com .
About TELUS International
TELUS International (NYSE and TSX: TIXT) designs, builds and delivers next-generation digital solutions to enhance the customer experience (CX) for global and disruptive brands. The company’s services support the full lifecycle of its clients’ digital transformation journeys and enable them to more quickly embrace next-generation digital technologies to deliver better business outcomes. TELUS International’s integrated solutions and capabilities span digital strategy, innovation, consulting and design, digital transformation and IT lifecycle solutions, data annotation and intelligent automation, and omnichannel CX solutions that include content moderation, trust and safety solutions and other managed solutions. Fueling all stages of company growth, TELUS International partners with brands across high growth industry verticals, including tech and games, communications and media, eCommerce and fintech, healthcare, and travel and hospitality. Learn more at: www.telusinternational.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210706005219/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release
Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
